Clinical research strategic sourcing solutions today: We work closely with you to provide market insights needed in order to implement the best strategy to meet your commercial drug supply requirements. Our client testimonials attest to our unique, collaborative approach, which adds longstanding value and strong partnerships. Our aim is to understand your goals and to work to minimize waste, allowing you to reinvest those savings back into your R&D initiatives. We hold ourselves to the highest standards, delivering on time, and most importantly, with uncompromised quality and integrity. Discover even more information at https://www.clientpharma.com/what-we-do/project-management/.
True commitment to patient safety: ClientPharma is also committed to proactively driving quality — not only because it’s the foundation from which the pharmaceutical industry has been built, but we also understand the significance of the patients’ safety and well-being. It’s our professional duty to service our clients’ needs with the utmost attention and care. CP also has a personal stake in supporting the development of future medicines that will treat and help eliminate life threatening diseases, ensuring we enhance our lives and those of our loved ones.
Unbeatable global access to commercial drug products – Unlike many comparator drug sourcing companies, our ethos is to challenge the norms and adapt to your specific needs. We understand the complexities and challenges of multi-faceted projects with time and temperature specifics. Using a combined understanding of your clinical requisites and our extensive knowledge of the commercial market landscape, we work to design a supply strategy unique to your needs. Ask our team for a customized product supply assessment.
Our temperature-controlled capabilities include 2°- 8°C and 15°- 25°C facilities, as well as access to specialist transport to manage deliveries around the world according to product temperature requirements. Extensive capabilities: Our capabilities include stock receipt, import & export expertise, in-territory regulatory specialists, product reconciliation and destruction services. You can trust us: Our highly trained logistics team is dedicated to providing a robust clinical trial supply chain and trusted product integrity with regulatory compliant distribution through validated temperature-controlled logistics. We provide the peace-of-mind you need, offering you with dedicated clinical trial supply chain solutions to meet the explicit needs of your clinical programs. See additional information on clientpharma.com.
ClientPharma (CP), a global clinical trial supply company, specializing in the procurement of commercial drug for clinical research, announced today it has formed a strategic partnership with TrialCard, a full-service life sciences commercialization partner. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers. TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.
When volatility of the market is coupled with the increasing complexity of the manufacturing process it creates a new drive for manufacturing solutions. Recently, pharmaceutical companies have begun to move away from conventional forms of manufacturing to use more flexible and modular models. These models are said to increase capacity, reduce costs and decrease development time in clinical trials. Flexibility in the manufacturing process also means that capacity for a drug can be scaled down to accommodate variability and volatility in the market. This can in turn reduce inaccurate estimates when supplying new medicines. Using this model, clients can then increase and decrease orders as and when they need to rather than bulk buying and ending up with surplus. In addition to these new approaches, disposable equipment has also become a major solution. Components such as hoses and bags are swapped over during the process, meaning that production never needs to stop. Although these approaches are often seen as more costly than traditional methods in the first instance, their benefits often out way their risks by creating a more flexible process.